OURO FINO SAÚDE ANIMAL LTDA has a total of 16 patent applications. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), Argentina and Uruguay. Its main competitors in its focus markets pharmaceuticals and biotechnology are VIROMETIX AG, GENITRIX LLC and ADVAXIS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Argentina | 3 | |
#3 | Uruguay | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Brazil | 1 | |
#6 | Mexico | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Romero Ramos Celso Raul | 5 |
#2 | Marroquin Quelopana Miryam | 5 |
#3 | Ramos Celso Raul Romero | 4 |
#4 | Celso Raul Romero Ramos | 3 |
#5 | Quelopana Miryam Marroquin | 3 |
#6 | Neto Dolivar Coraucci | 3 |
#7 | Baruselli Pietro Sampaio | 3 |
#8 | Miryam Marroquin Quelopana | 3 |
#9 | Macedo Gustavo Guerino | 3 |
#10 | Coraucci Neto Dolivar | 1 |
Publication | Filing date | Title |
---|---|---|
EP3156487A1 | Escherichia coli t7 expression vector, vectors for the co-expression and co-purification of recombinant peptides in/with carrier proteins, use of expression vectors for obtaining complexes with multiple antigens and immunomodulators | |
WO2015188240A1 | Escherichia coli t7 expression vector, vectors for the co-expression and co-purification of recombinant peptides in/with carrier proteins, use of expression vectors for obtaining complexes with multiple antigens and immunomodulators | |
WO2015051431A1 | Method for producing active recombinant bovine somatrotopin, and thus obtained product | |
WO2014165956A1 | Pharmaceutical compositions comprising kisspeptin or derivatives thereof | |
BR102014005376A2 | inhibin alpha antigen, inhibin alpha coding gene, fusion protein encoding gene, process of obtaining inhibin alpha antigen, antigenic composition, use of inhibin alpha antigen, and use of antigenic composition |